Comparison of the effect of rose and metoclopramide on nausea and vomiting in pregnancy
Phase 3
- Conditions
- nausea and vomiting during pregnancy.nausea and vomiting of pregnancy
- Registration Number
- IRCT20170628034792N4
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
women with first and second intentionally pregnancy
between 7 to 14 weeks of gestation
mild to moderate nausea and vomiting
nausea and vomiting have not improved with diet and usual dietary regimens
not having other systemic diseases and multiple pregnancies
mild to moderate Longing
Exclusion Criteria
Hepatitis, gastritis, increased intracranial pressure and pancreatitis
complications of pregnancy including threatened abortion
bleeding
pyelonephritis.
requirement the person to take medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: In 5 days after treatment and three times per day. Method of measurement: visual scale and Rhodes Index 1 to 10.
- Secondary Outcome Measures
Name Time Method